Page 8 - Nasdaq Fold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

William Blair Investment Management LLC increased its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) by 0.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,101,186 shares of the biopharmaceutical company’s stock after acquiring an additional 15,822 shares during the period. […]

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) was the recipient of unusually large options trading activity on Wednesday. Stock traders bought 5,091 call options on the stock. This is an increase of 1,745% compared to the typical volume of 276 call options. Amicus Therapeutics Price Performance Shares of FOLD stock traded up $0.14 during midday […]

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) fell 5.1% during trading on Tuesday . The stock traded as low as $10.55 and last traded at $10.63. 136,884 shares traded hands during mid-day trading, a decline of 94% from the average session volume of 2,277,192 shares. The stock had previously closed at $11.20. Wall Street Analysts […]

Fiera Capital Corp increased its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) by 29.2% in the 4th quarter, Holdings Channel reports. The firm owned 5,189,157 shares of the biopharmaceutical company’s stock after purchasing an additional 1,172,602 shares during the period. Fiera Capital Corp’s holdings in Amicus Therapeutics were worth $63,360,000 at […]

Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the six research firms that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year […]